MHC class I signaling: new functional perspectives for an old molecule

Area of Science:

• Transplantation immunology
• Solid organ transplantation
• Allograft rejection

Background:

• Donor-specific antibodies (DSAs) are linked to refractory rejection and poor outcomes in solid organ transplantation.
• Understanding of antibody-mediated allograft injury is evolving beyond complement deposition.
• Alloantibody mechanisms are crucial for understanding transplant vasculopathy and antibody-mediated rejection.

Purpose of the Study:

• To review the direct effects of alloantibodies on the endothelium.
• To explore how these effects contribute to transplant vasculopathy and antibody-mediated rejection.
• To advance the knowledge of unique alloantibody mechanisms in transplantation.

Main Methods:

• Review of current literature on alloantibody mechanisms.
• Analysis of direct endothelial effects of alloantibodies.
• Synthesis of information on leukocyte recruitment, chemokine and cytokine production, and alloresponses.

Main Results:

• Alloantibodies exert direct effects on the endothelium.
• These effects include leukocyte recruitment, chemokine and cytokine release, and stimulation of immune responses.
• These mechanisms are key drivers of transplant vasculopathy and antibody-mediated rejection.

Conclusions:

• Unique alloantibody mechanisms, particularly direct endothelial effects, are critical in solid organ transplantation.
• These mechanisms offer new insights into antibody-mediated rejection and transplant vasculopathy.
• Further research into these pathways can improve allograft survival and patient outcomes.